Evotec SE (EVT.BE)
Berlin - Berlin Delayed price. Currency in EUR
Add to watchlist
As of 08:34PM CET. Market open.
| Previous close | 17.92 |
| Open | 17.99 |
| Bid | 17.83 x 145200 |
| Ask | 18.51 x 140700 |
| Day's range | 17.99 - 18.35 |
| 52-week range | 14.81 - 29.71 |
| Volume | |
| Avg. volume | 142 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 28 Mar 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Sernova and Evotec on Track to Initiate Clinical Testing of the First iPSC-Derived Islets in Cell Pouch as a Potential Functional Cure for Type 1 Diabetes
First iPSC-derived commercially viable off-the-shelf islet combination product is advancing towards regulatory filing in 2024 for anticipated clinical trial authorization to treat patients with Type 1 Diabetes (T1D) and severe hypoglycemiaiPSC islet-like cluster manufacturing scale-up and tech transfer activities are well under way in preparation for first human clinical evaluationT1D preclinical models with iPSC derived islet clusters transplanted in Sernova’s Cell Pouch has now demonstrated co
- Simply Wall St.
With 47% ownership, Evotec SE (ETR:EVT) has piqued the interest of institutional investors
To get a sense of who is truly in control of Evotec SE ( ETR:EVT ), it is important to understand the ownership...
- Simply Wall St.
Earnings Miss: Evotec SE Missed EPS And Analysts Are Revising Their Forecasts
Last week saw the newest quarterly earnings release from Evotec SE ( ETR:EVT ), an important milestone in the company's...
© 2023 Yahoo. All rights reserved.
